Taro Pharmaceutical Industries (TARO) Revenue & Revenue Breakdown


OverviewFinancialsChart

Taro Pharmaceutical Industries Revenue Highlights


Latest Revenue (Y)

$629.18M

Latest Revenue (Q)

$164.94M

Main Geography (Y)

United States

Taro Pharmaceutical Industries Revenue by Period


Taro Pharmaceutical Industries Revenue by Year

DateRevenueChange
2024-03-31$629.18M9.81%
2023-03-31$572.95M2.07%
2022-03-31$561.35M2.25%
2021-03-31$548.97M-14.86%
2020-03-31$644.77M-3.75%
2019-03-31$669.89M1.21%
2018-03-31$661.91M-24.73%
2017-03-31$879.39M-7.51%
2016-03-31$950.75M10.18%
2015-03-31$862.94M13.65%
2014-03-31$759.28M13.16%
2013-03-31$670.95M23.55%
2012-03-31$543.08M38.35%
2010-12-31$392.54M9.76%
2009-12-31$357.64M8.69%
2008-12-31$329.04M2.97%
2007-12-31$319.55M26.67%
2006-12-31$252.27M-15.27%
2005-12-31$297.74M4.79%
2004-12-31$284.13M-9.93%
2003-12-31$315.46M49.10%
2002-12-31$211.58M40.93%
2001-12-31$150.13M44.64%
2000-12-31$103.80M23.88%
1999-12-31$83.78M25.61%
1998-12-31$66.70M9.34%
1997-12-31$61.00M7.96%
1996-12-31$56.50M13.91%
1995-12-31$49.60M17.81%
1994-12-31$42.10M47.72%
1993-12-31$28.50M-

Taro Pharmaceutical Industries generated $629.18M in revenue during NA 2024, up 9.81% compared to the previous quarter, and up 93.92% compared to the same period a year ago.

Taro Pharmaceutical Industries Revenue by Quarter

DateRevenueChange
2024-03-31$164.94M4.96%
2023-12-31$157.15M6.03%
2023-09-30$148.20M-6.73%
2023-06-30$158.89M8.40%
2023-03-31$146.59M5.31%
2022-12-31$139.20M6.67%
2022-09-30$130.50M-16.70%
2022-06-30$156.66M9.35%
2022-03-31$143.26M3.08%
2021-12-31$138.98M5.30%
2021-09-30$131.99M-10.28%
2021-06-30$147.11M-0.83%
2021-03-31$148.35M5.85%
2020-12-31$140.15M-1.89%
2020-09-30$142.84M21.43%
2020-06-30$117.63M-32.76%
2020-03-31$174.94M18.46%
2019-12-31$147.68M-8.19%
2019-09-30$160.85M-0.28%
2019-06-30$161.30M-10.35%
2019-03-31$179.92M2.01%
2018-12-31$176.38M10.95%
2018-09-30$158.97M2.82%
2018-06-30$154.62M-11.76%
2018-03-31$175.22M12.71%
2017-12-31$155.46M-8.51%
2017-09-30$169.91M5.33%
2017-06-30$161.32M-17.87%
2017-03-31$196.41M-10.88%
2016-12-31$220.40M-3.67%
2016-09-30$228.79M-2.13%
2016-06-30$233.78M-11.80%
2016-03-31$265.07M2.61%
2015-12-31$258.34M21.83%
2015-09-30$212.06M-1.50%
2015-06-30$215.28M-11.84%
2015-03-31$244.18M2.73%
2014-12-31$237.70M-5.24%
2014-09-30$250.83M92.61%
2014-06-30$130.23M-30.42%
2014-03-31$187.18M-12.37%
2013-12-31$213.60M4.03%
2013-09-30$205.32M34.02%
2013-06-30$153.19M-7.23%
2013-03-31$165.13M-11.07%
2012-12-31$185.69M15.36%
2012-09-30$160.97M1.14%
2012-06-30$159.15M9.65%
2012-03-31$145.14M-2.00%
2011-12-31$148.10M7.13%
2011-09-30$138.25M23.90%
2011-06-30$111.58M3.58%
2011-03-31$107.73M5.57%
2010-12-31$102.05M-1.13%
2010-09-30$103.22M5.36%
2010-06-30$97.97M10.02%
2010-03-31$89.04M8.49%
2009-12-31$82.08M-12.55%
2009-09-30$93.86M-3.06%
2009-06-30$96.82M14.05%
2009-03-31$84.89M17.26%
2008-12-31$72.40M-19.95%
2008-09-30$90.44M2.61%
2008-06-30$88.14M0.39%
2007-12-31$87.80M21.19%
2005-12-31$72.45M-

Taro Pharmaceutical Industries generated $164.94M in revenue during Q4 2024, up 4.96% compared to the previous quarter, and up 118.49% compared to the same period a year ago.

Taro Pharmaceutical Industries Revenue Breakdown


Taro Pharmaceutical Industries Revenue Breakdown by Country

Annual Revenue by Country

CountryMar 23Mar 22Mar 21Mar 20Mar 19
CANADA$136.24M$130.07M---
United States$363.06M$376.68M---
Other Country-$6.69M$8.40M$8.28M$8.76M
ISRAEL-$47.91M$46.57M$42.82M$40.05M
Canada And Cayman Islands--$110.17M$98.00M$83.97M
UNITED STATES--$383.83M$495.67M$537.11M

Taro Pharmaceutical Industries's latest annual revenue breakdown by geography, as of Mar 23: United States (72.71%), and CANADA (27.29%).

Taro Pharmaceutical Industries Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
RDYDr. Reddy's Laboratories$279.16B-
PBHPrestige Consumer Healthcare$1.13B$283.55M
PAHCPhibro Animal Health$977.89M$273.16M
EVOEvotec SE$781.43M$208.73M
PCRXPacira BioSciences$674.98M$168.57M
SUPNSupernus Pharmaceuticals$607.52M$175.69M
AMPHAmphastar Pharmaceuticals$593.24M$188.82M
COLLCollegium Pharmaceutical$566.77M$159.30M
ANIPANI Pharmaceuticals$486.82M$148.33M
ORGOOrganogenesis$433.14M$115.18M
LFCRLifecore Biomedical$128.26M$24.70M
RDHLRedHill Biopharma$6.51M$1.80M

TARO Revenue FAQ


What is Taro Pharmaceutical Industries’s yearly revenue?

Taro Pharmaceutical Industries's yearly revenue for 2024 was $629.18M, representing an increase of 9.81% compared to 2023. The company's yearly revenue for 2023 was $572.95M, representing an increase of 2.07% compared to 2022. TARO's yearly revenue for 2022 was $561.35M, representing an increase of 2.25% compared to 2021.

What is Taro Pharmaceutical Industries’s quarterly revenue?

Taro Pharmaceutical Industries's quarterly revenue for Q4 2024 was $164.94M, a 4.96% increase from the previous quarter (Q3 2024), and a 12.52% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $157.14M, a 6.03% increase from the previous quarter (Q2 2024), and a 12.89% increase year-over-year (Q3 2023). TARO's quarterly revenue for Q2 2024 was $148.2M, a -6.73% decrease from the previous quarter (Q1 2024), and a 13.57% increase year-over-year (Q2 2023).

What is Taro Pharmaceutical Industries’s revenue growth rate?

Taro Pharmaceutical Industries's revenue growth rate for the last 3 years (2022-2024) was 12.08%, and for the last 5 years (2020-2024) was -2.42%.